Page last updated: 2024-09-04

docetaxel anhydrous and fr 190997

docetaxel anhydrous has been researched along with fr 190997 in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(fr 190997)
Trials
(fr 190997)
Recent Studies (post-2010) (fr 190997)
12,1103,2166,9202506

Protein Interaction Comparison

ProteinTaxonomydocetaxel anhydrous (IC50)fr 190997 (IC50)
B2 bradykinin receptorCavia porcellus (domestic guinea pig)0.0023
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0004
B2 bradykinin receptorHomo sapiens (human)0.0004

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Afratis, K; Gavras, H; Karamanos, NK; Koutsakis, C; Leonardi, S; Papaioannou, D; Piperigkou, Z; Rassias, G; Rigopoulou, D; Vachlioti, E1

Other Studies

1 other study(ies) available for docetaxel anhydrous and fr 190997

ArticleYear
Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved?
    European journal of medicinal chemistry, 2021, Jan-15, Volume: 210

    Topics: Anti-Bacterial Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; MCF-7 Cells; Quinolines; Receptor, Bradykinin B2

2021
chemdatabank.com